News

Retatrutide at ADA 2026: Triple-Agonist vs. Tir...

ADA 2026 may bring new retatrutide data, but head-to-head trials against tirzepatide are still missing. We examine what clinicians need to know about

Tirzepatide Medicare Coverage: What July 1 Mean...

Medicare Part D will cover tirzepatide for weight loss starting July 1, 2025, expanding access for older adults. This article examines the policy's implications